Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

9WY1

Cryo-EM structure of Fks1 in apo state

Summary for 9WY1
Entry DOI10.2210/pdb9wy1/pdb
EMDB information66359
Descriptor1,3-beta-glucan synthase component FKS1, 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, (2S)-3-(hexadecanoyloxy)-2-[(9Z)-octadec-9-enoyloxy]propyl 2-(trimethylammonio)ethyl phosphate, ... (5 entities in total)
Functional Keywords1, 3-beta-glucan synthase component fks1, membrane protein
Biological sourceSaccharomyces cerevisiae S288C
Total number of polymer chains1
Total formula weight223427.43
Authors
You, Z.L.,Bai, L. (deposition date: 2025-09-26, release date: 2026-02-18)
Primary citationYou, Z.L.,Sun, L.,Wang, L.X.,Ni, Y.R.,Lyu, R.Q.,Chen, D.D.,Yun, C.H.,Song, T.,Song, Y.,Bai, L.
Inhibition mechanism of the fungal beta-1,3-glucan synthases by triterpenoid antifungal drugs.
Nat Commun, 2026
Cited by
PubMed Abstract: β-1,3-glucan synthase is the molecular target for triterpenoid and echinocandin antifungal drugs in clinical. It catalyzes the formation of β-1,3-glucan, which is the primary component of the fungal cell wall. However, the inhibition mechanism of β-1,3-glucan synthase by triterpenoid drugs remains unclear. In this study, we report cryo-electron microscopy (cryo-EM) structures of Saccharomyces cerevisiae β-1,3-glucan synthase Fks1 and Fks2 in the apo state, the triterpenoid drug enfumafungin-bound state, and an open state. Structural analysis along with mutagenesis reveals the enfumafungin binding site, and the mechanism of the clinical drug-resistant mutations of the β-1,3-glucan synthases. Remarkably, the enfumafungin attaches on a single transmembrane helix TM5 of the β-1,3-glucan synthases, reorganizes its nearby lipid environment, and stabilizes the enzyme in a specific basal state with intact active site. Moreover, we elucidate that both the basal state and the open state are essential for FKS's glycosyltransferase activity. Our research also shows that Fks2 is highly conserved with Fks1 in terms of structure, activity, and drug inhibition. These findings provide deep insights into the fungal cell wall synthesis, and will facilitate the development of antifungal drugs targeting β-1,3-glucan synthase.
PubMed: 41639077
DOI: 10.1038/s41467-026-69114-8
PDB entries with the same primary citation
Experimental method
ELECTRON MICROSCOPY (3.23 Å)
Structure validation

249697

PDB entries from 2026-02-25

PDB statisticsPDBj update infoContact PDBjnumon